How Much Did Redfield Raise?
Funding & Key Investors

Redfield has successfully secured a significant capital injection, bringing its total funding to $58K. This latest financing round, which contributed $58K in substantial expansion capital, underscores the market confidence in the company's specialized medical device portfolio. By leveraging this investment, Redfield is positioned to accelerate its operational footprint within the outpatient clinical sector, reinforcing its commitment to non-surgical therapeutic advancements.

What is Redfield?

Redfield
ManufacturingMedical Devices & Equipment

Redfield Corp. operates at the intersection of clinical precision and patient-centric medical technology. The company is primarily recognized for the development and distribution of the Infrared Coagulator, a sophisticated non-surgical instrument utilized for a diverse range of medical applications, including the treatment of hemorrhoids, anal dysplasia, and chronic rhinitis. With a legacy spanning over two decades, the firm has established a robust reputation for delivering safe, effective, and efficient procedural outcomes. The Infrared Coagulation (IRC) methodology is specifically engineered for office-based settings, offering healthcare providers a streamlined, user-friendly solution that benefits from favorable reimbursement structures under both Medicare and private insurance frameworks. By prioritizing minimal training requirements and rapid patient recovery, Redfield maintains a competitive edge in the medical device landscape, effectively bridging the gap between complex surgical intervention and accessible, high-quality outpatient care.

How much funding has Redfield raised?

Redfield has raised a total of $58K across 1 funding round:

2021

Debt

$58K

Debt (2021): $58K with participation from PPP

Key Investors in Redfield

PPP

Public-Private Partnership

What's next for Redfield?

With the recent infusion of capital, Redfield is strategically poised to scale its market penetration and enhance its research and development pipeline. The company's trajectory suggests a focus on expanding the clinical adoption of its IRC technology, potentially targeting new therapeutic indications or geographic markets. As the healthcare industry continues to shift toward minimally invasive, cost-effective office procedures, Redfield is well-positioned to capitalize on these macro trends. Future growth will likely involve optimizing supply chain efficiencies and deepening relationships with clinical practitioners to ensure the continued dominance of their proprietary coagulation technology in the outpatient surgical market.

See full Redfield company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Industrial Machinery & EquipmentManufacturingCleaning Products
Boats & SubmarinesManufacturingCivil Engineering ConstructionConstruction
Industrial Machinery & EquipmentManufacturing
ManufacturingMedical Devices & Equipment

Frequently Asked Questions Regarding Redfield Financial Insights

What are the most recent funding rounds that Redfield has completed, and what were the funding rounds?
Redfield has recently completed 1 funding rounds: Debt on Jan 30, 2021.
What is the total amount of funding Redfield has raised to date?
Redfield has raised a total of $58K in funding to date.
How many funding rounds has Redfield completed?
Redfield has completed 1 funding rounds.
How much funding did Redfield raise in its most recent funding round?
Redfield raised $58K in its most recent funding round.
Who are the lead investors in Redfield's latest funding round?
The lead investor in Redfield's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Redfield's history?
The largest funding round in Redfield's history was $58K.
See more information about Redfield